Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Gross Margin (2019 - 2025)

Pulmonx has reported Gross Margin over the past 7 years, most recently at 74.65% for Q3 2025.

  • Quarterly Gross Margin rose 95.0% to 74.65% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 73.3% through Sep 2025, down 86.0% year-over-year, with the annual reading at 74.0% for FY2024, 9.0% up from the prior year.
  • Gross Margin was 74.65% for Q3 2025 at Pulmonx, up from 72.11% in the prior quarter.
  • Over five years, Gross Margin peaked at 75.21% in Q1 2022 and troughed at 71.52% in Q1 2021.
  • The 5-year median for Gross Margin is 73.99% (2021), against an average of 73.79%.
  • Year-over-year, Gross Margin surged 4644bps in 2021 and then plummeted -235bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 74.78% in 2021, then decreased by -3bps to 72.51% in 2022, then rose by 3bps to 74.7% in 2023, then dropped by -1bps to 74.02% in 2024, then rose by 1bps to 74.65% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Gross Margin are 74.65% (Q3 2025), 72.11% (Q2 2025), and 72.51% (Q1 2025).